Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension
Angiotensin II is a key player in the pathogenesis of renovascular hypertension, a condition associated with endothelial dysfunction. We investigated aliskiren (ALSK) and L-arginine treatment both alone and in combination on blood pressure (BP), and vascular reactivity in aortic rings. Hypertension...
Main Authors: | C.H. Santuzzi, R.V. Tiradentes, V. Mengal, E.R.G. Claudio, H. Mauad, S.A. Gouvea, G.R. Abreu |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2015-01-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000100065&lng=en&tlng=en |
Similar Items
-
ALISKIREN (RENIN INHIBITOR) AS THE RECENT ANTIHYPERTENSIVE MODALITY
by: Luh Gde Primahatini Suaka Putri
Published: (2013-12-01) -
Effect of aliskiren, telmisartan and torsemide on cardiac dysfunction in l-nitro arginine methyl ester (l-NAME) induced hypertension in rats
by: Sawsan A. Sadek, et al.
Published: (2015-11-01) -
Clinical and economic impact of aliskiren in uncontrolled hypertensive patients
by: Ezio Degli Esposti, et al.
Published: (2012-03-01) -
Effects of Paricalcitol and Aliskiren Combination Therapy on Experimental Diabetic Nephropathy Model in Rats
by: Zehra Eren, et al.
Published: (2014-12-01) -
Aliskiren, the first direct renin inhibitor for treatment of hypertension: The path of its development
by: M Jadhav, et al.
Published: (2012-01-01)